← Sotera Health Co SHC
Market Price
$18.89
Market Cap
$5.42B
P/E Ratio
N/A
Revenue (FY 2025)
↑5.7% YoY
$1.16B
3-Yr CAGR: 5.1%
Net Income
↑75.6% YoY
$77.95M
Net Margin: 6.7%
Free Cash Flow
↑22.4% YoY
$261.87M
FCF Yield: 4.83%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
12.9%
ROA: 2.4%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (SHC)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2019 | $778.3M | — | $395.4M | $-20.9M | — | — | — | $149.0M | $143.8M | — |
| FY 2020 | $818.2M | +5.1% | $443.6M | $-38.6M | -85.2% | — | — | $120.6M | $106.3M | -26.1% |
| FY 2021 | $931.5M | +13.9% | $518.7M | $116.9M | +402.7% | — | — | $281.5M | $267.0M | +151.2% |
| FY 2022 | $1,003.7M | +7.8% | $557.0M | $-233.6M | -299.8% | — | — | $278.0M | $261.5M | -2.0% |
| FY 2023 | $1,049.3M | +4.5% | $577.2M | $51.4M | +122.0% | — | — | $-147.7M | $-164.5M | -162.9% |
| FY 2024 | $1,100.4M | +4.9% | $602.3M | $44.4M | -13.6% | — | — | $224.2M | $214.0M | +230.1% |
| FY 2025 | $1,163.6M | +5.7% | $645.5M | $77.9M | +75.6% | — | — | $287.2M | $261.9M | +22.4% |
Valuation
Market Price
$18.89
Market Cap
$5.42B
Enterprise Value
$7.21B
P/E Ratio
N/A
P/B Ratio
8.89
FCF Yield
4.83%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
55.48%
Operating Margin
12.68%
Net Margin
6.70%
Return on Equity (ROE)
12.86%
Return on Assets (ROA)
2.39%
Asset Turnover
0.36x
Revenue 3-Yr CAGR
5.05%
Financial Health & Liquidity
Current Ratio
8.87
Cash Ratio
46.82
Debt / Equity
3.509
Debt / Assets
0.652
Cash & Equivalents
$344.62M
Total Debt
$2.13B
Book Value / Share
$2.13
Cash Flow Efficiency
Operating Cash Flow
$287.19M
Capital Expenditures (CapEx)
$25.33M
Free Cash Flow
$261.87M
OCF / Revenue
24.68%
FCF / Revenue
22.50%
FCF 3-Yr CAGR
0.04%
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$2.13
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$3.26B
Total Liabilities
$2.66B
Stockholders' Equity
$606.03M
Current Assets
$65.25M
Current Liabilities
$7.36M